Skip to main content

Table 2 Prevalence (%) at baseline of swollen, erosive and swollen erosive joints in the total AGREE cohort (N = 509)

From: Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study

 

Swelling

Erosion

Swelling and erosion

Large joint

  

Ankle

79.2

–

 

Knee

68.4

–

 

Elbow

48.1

–

 

Shoulder

33.8

–

 

TMJ

8.8

–

 

Medium joint

   

Wrist

91.9

42.5

39.5

Small joint

   

MCP1

75.1

27.6

22.1

MCP2

89.1

19.5

18.6

MCP3

83.6

18.6

17.4

MCP4

49.8

5.9

3.6

MCP5

50.4

9.1

6.3

IP1

53.6

6.7

3.8

PIP2

74.3

6.9

4.7

PIP3

78.2

11.6

9.3

PIP4

61.0

6.7

5.1

PIP5

51.2

6.1

4.7

MTP1

44.6

24.3

10.1

MTP2

51.8

19.7

12.3

MTP3

51.0

25.0

14.0

MTP4

40.1

17.3

8.5

MTP5

30.0

43.5

12.5

  1. N, number of patients; TMJ, temporomandibular joint; MCP metacarpophalangeal joints; IP, interphalangeal joint; PIP, proximal interphalangeal joints; MTP, metatarsophalangeal joints
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us